SCHEMBL4982091

SCHEMBL4982091

FC(F)(F)Oc1ccccc1C1(c2ccccc2OC(F)(F)F)CO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.43
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
DDB1 Q16531 2/20 0.38
CRBN Q96SW2 2/20 0.38
EPHX2 P34913 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GAA P10253 1/20 0.36
CNR2 P34972 1/20 0.35
C1R P00736 1/20 0.35
SCN9A Q15858 1/20 0.34
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HSD11B1 P28845 1/20 0.33
S1PR1 P21453 2/20 0.32
DRD2 P14416 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11451794 0.73 ALDH1A1 (0.38) ALDH1A1GAA
SCHEMBL4654446 0.73 RXRA (0.47) ALDH1A1L3MBTL1DDB1CRBNEPHX2
SCHEMBL18769575 0.73 BACE1 (0.38) BACE1HDAC6HSD11B1
SCHEMBL760881 0.73 BACE1 (0.36) BACE1ALDH1A1L3MBTL1DDB1CRBN
SCHEMBL760883 0.73 BACE1 (0.36) BACE1ALDH1A1L3MBTL1DDB1CRBN
Hydrochloric Acid SCHEMBL18742745 0.72 BACE1 (0.38) BACE1
SCHEMBL14893791 0.71 BACE1 (0.35) BACE1ALDH1A1L3MBTL1HDAC6SCN9A
SCHEMBL27907663 0.70 HDAC4 (0.40) BACE1ALDH1A1L3MBTL1DDB1CRBN
SCHEMBL624931 0.69 GAA (0.35) BACE1ALDH1A1L3MBTL1DDB1CRBN
SCHEMBL19469649 0.69 AKR1C1 (0.46) ALDH1A1L3MBTL1GAARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed